Chronic kidney disease: Absence of evidence or evidence of absence? ACS treatment in CKD

Nature Reviews Nephrology

Volumn 6, Issue 8, 2010, Pages 449-450

  Rifkin, Dena E ^a   Sarnak, Mark J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; KIDNEY FAILURE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT PLANNING; COMPLICATION; HEALTH; INCIDENCE; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

ACUTE CORONARY SYNDROME; GLOBAL HEALTH; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 77955073634     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2010.82     Document Type: Short Survey

References (9)

1. Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296-1305 (2004).
2. Anavekar, N. S. et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med. 351, 1285-1295 (2004).
3. Winkelmayer, W. C., Levin, R. & Setoguchi, S. Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin. J. Am. Soc. Nephrol. 3, 1415-1422 (2008).
4. Fox, C. S. et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and intervention Outcomes Network registry. Circulation 121, 357-365 (2010).
5. Chertow, G. M., Normand, S. L. & McNeil, B. J. " Renalism " : inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J. Am. Soc. Nephrol. 15, 2462-2468 (2004).
6. Coca, S. G., Krumholz, H. M., Garg, A. X. & Parikh, C. R. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296, 1377-1384 (2006).
7. Shlipak, M. G. et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann. Intern. Med. 137, 555-562 (2002).
8. Wanner, C. et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353, 238-248 (2005). (Pubitemid 41058323)
9. Fellstrom, B. C. et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N. Engl. J. Med. 360, 1395-1407 (2009).